Seres Therap (MCRB)
Seres Therapeutics, Inc., a clinical-stage company, focuses on developing biotherapeutics for serious diseases. The company develops SER-155, an investigational...
- Open
- 5.000
- High
- 5.145
- Low
- 4.710
- Prev. Close
- 5.010
- Volume
- 54.05K
- Turnover
- 262.73K
- Avg Price
- 4.861
- Bid/Ask Ratio
- --
- Amplitude
- 8.68%
- 52wk High
- 29.980
- Volume Ratio
- 1.14
- Turnover Ratio
- 0.61%
Seres Therap Analyst Rating
View moreForecast & Rating
Aug 5, 2026Price forecast
$17.00259.41%
Forecast & RatingStrong buy
2analysts
- Strong buy100.00%
- Buy0.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
News
- CoinLive · Sep 9 at 01:36 AM
STOCKS | Taikoo A Hits Record High As Seven Other Stocks See Unusual Moves
- StockTitan · Sep 8 at 02:00 PM
Seres Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | MCRB Stock News
- Market Beat · Sep 3 at 07:20 AM
Seres Therapeutics (NASDAQ:MCRB) Stock Price Crosses Above 50 Day Moving Average - Should You Sell?
- PUBT · Sep 1 at 11:02 AM
Seres Therapeutics to present at H.C. Wainwright Global Investment Conference
